A Clinical Randomized Control Trial of Combination TACE With and Without Low-Molecular-Weight Heparin in Hepatocellular Carcinoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Epirubicin; Ethiodized oil; Fluorouracil; Nadroparin calcium
- Indications Liver cancer
- Focus Therapeutic Use
Most Recent Events
- 01 Apr 2016 Biomarkers information updated
- 18 Jun 2009 Additional lead trial investigator Jiamei Yang, lead centres identified as reported by Chinese Clinical Trial Register.
- 18 Jun 2009 New source identified and integrated (Chinese Clinical Trial Register).